Best Agrolife Ltd. · NSE:BESTAGRO
Best Agrolife — Q1 FY27 Earnings Presentation
16 slides from Best Agrolife's earnings presentation, Jul 30, 2026
Slide 1: Exchange filing cover letter: intimation under Regulation 30
WBest affotirelimited CIN : 1741 IODLt992pLC116773 3Oth fuly, 2026 To National Stock Exchange of India Limited IISE Limited Exchange Plaza, C-1, Block-G, 25th Floor, P.f. Towers, Bandra - Kurla Complex Dalal Street, Mumbai-4O0001 Bandra (E), Mumbai-400051 SCRIP CODE: 539660 SCRIP ID: BESTAGRO sub: I
Slide 2: Financial Highlights Q1 FY26-27
F I N A N C I A L H I GH LI G HT S Q1 FY26-27
Slide 3: Disclaimer
DISCLAIMER The Presentation is to provide the general background information about the company’s activities as at the date of the presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any i
Slide 4: Table of Contents
TABLE OF CONTENTS Company Overview From MD’s Desk Patent Power Q1 FY27 Highlights Way Ahead
Slide 5: Company Overview
COMPAN Y OVERVIEW 13th 40 11+ 10,900+ Warehouses Patented Dealers Largest Indian 21 States Products Agrochemical Company* 4 530+ 800+ Manufacturing units Formulations Employees 7000 MTPA Technical Registrations 35500 KL Formulation *Agropages Top 20 Indian Agrochemical Companies
Slide 6: From MD's Desk
FROM M D’s DESK "The first quarter of FY27 reflects the strength of our business model and the progress we have made in building a differentiated product portfolio. Despite a delayed onset of the monsoon and uneven rainfall across several parts of India, which affected Kharif sowing and delayed crop
Slide 7: Key Patented Products
KEY PATEN TED PRODUCTS P A T E N T P O W E R RONFENTM TRICOLOR TM DINOTREX TM NEMAGENTM SHOT DOWNTM Insecticide (SC) Fungicide (SC) Insecticide + Fungicide (WG) Insecticide (SC) Herbicide (ME) Pyriproxyfen - 8% Trifloxystrobin - 10% Pymetrozine - 30% Chlorantraniliprole - 4.5% Haloxyfop-R Methyl - 1
Slide 8: Patented Innovations: Latest Launches
LATEST LAUNCHES PAT E N T E D I N N O VAT I O N S . P R O V E N P E R F O R M A N C E . FLUZAMTM CUBAX POWER MIDCOTINTM Insecticide + Fungicide (FS) EXTRATM Insecticide + Fungicide (SE) Insecticide (SC) Trifloxystrobin - 4% lsoprothiolane - 15% Fluxapyroxad - 6.66% Spiromesifen - 15% Trifloxystrobin
Slide 9: Bio-Fertilizers / Plant Growth Regulators
BIO-FERTILIZERS / PLANT GROWTH REGULATORS N AT U R E ' S I N T E L L I G E N C E . E N H A N C E D C R O P P E R F O R M A N C E . PUNCTUALTM SPRINKTM RICHGROW GOLDTM TORNETTM EMPROLE TM It is an organic potassium It is a highly concentrated It harnesses the natural power of It is a powerful bio- It
Slide 10: Highlights Q1 FY27 Financial Performance
HIG HLIGHTS Q1 FY27 01 Financial Performance • Revenue increased to ₹396 crore, compared to ₹381 crore in Q1 FY26. • Gross margin improved to 37% from 29% in Q1 FY26, driven by a favorable product mix which includes a 37% increase in volume of patented products. • EBITDA margin rose from 12% in Q1 F
Slide 11: Financial Highlights
FIN ANCIAL HIGHLIGHTS Revenue from operations EBITDA* (₹ Crore) (₹ Crore) 381 396 46 78 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 PAT EPS (₹ Crore) 1.15 20 41 8.42 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 *EBITDA is calculated excluding other income
Slide 12: The Branded Business
THE BRA NDED BUS INES S Branded v/s Institutional Sales Contribution of Patented products in Branded Sales 35% 39% 36% 55% 65% 61% 45% 64% Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 Branded Institutional Sales Patented Non-Patented
Slide 13: Consolidated P&L for Q1 FY27
CONS OLIDATED P&L FOR Q1 FY27 Value (INR Cr) Q1 FY27 Q1 FY26 Y-o-Y Q4 FY26 Q-o-Q Revenue from Operations 396 381 4% 156 154% Gross Margin 146 111 32% 35 315% EBITDA* 78 46 70% (27) 388% EBITDA Margin (%) 20% 12% 8% (17)% 37% Profit After Tax 41 20 104% (37) 209% PAT Margin (%) 10% 5% 5% (24)% 143% *
Slide 14: Consolidated P&L for Q1 FY27 (detailed)
CONS OLIDATED P&L FOR Q1 FY27 Value (INR Cr) Q1 FY27 Q1 FY26 Y-o-Y Q4 FY26 Revenue from Operations 396 381 4% 156 Other Income 2 4 1 Total Revenue 398 385 3% 157 Cost of Goods Sold 250 271 121 Employee Benefits Expense 25 25 25 Other Operating Expenses 43 40 37 Total Expenses 318 335 183 EBITDA* 78
Slide 15: Experienced Management Team
EXPERIENCED M ANAGEMEN T TEAM Mr. Vimal Alawadhi Mr. P. N. Karlekar Mr. N Surendra Sai Mr. Vikas Jain Managing Director Managing Director Head International Business Chief Financial Officer A t rue vi si onar y and a pa ss iona te A chemi cal Engi nee r fr om UD CT - one of A pa ss iona te t echnol
Slide 16: Thank You
THANK YOU !!! Contact Us: ir@bestagrolife.com (Investor Relations) D IS CLAIM ER This presentation includes certain forward looking statements and information including statements concerning the outlook for business. The statements are based on certain expectations, assumptions, anticipated developm